| Original language | English (US) |
|---|---|
| Pages (from-to) | 746-748 |
| Number of pages | 3 |
| Journal | Archives of Pathology and Laboratory Medicine |
| Volume | 141 |
| Issue number | 6 |
| DOIs | |
| State | Published - Jun 1 2017 |
ASJC Scopus subject areas
- Pathology and Forensic Medicine
- Medical Laboratory Technology
Cite this
FDA oversight of laboratory-developed tests where are we now? / Gatter, Ken.
In: Archives of Pathology and Laboratory Medicine, Vol. 141, No. 6, 01.06.2017, p. 746-748.Research output: Contribution to journal › Editorial
Gatter, K 2017, 'FDA oversight of laboratory-developed tests where are we now?', Archives of Pathology and Laboratory Medicine, vol. 141, no. 6, pp. 746-748. https://doi.org/10.5858/arpa.2017-0053-ED
@article{09f747e5a8374b6ba278dd62a62f8599,
title = "FDA oversight of laboratory-developed tests where are we now?",
author = "Ken Gatter",
year = "2017",
month = "6",
day = "1",
doi = "10.5858/arpa.2017-0053-ED",
language = "English (US)",
volume = "141",
pages = "746--748",
journal = "Archives of Pathology and Laboratory Medicine",
issn = "0003-9985",
publisher = "College of American Pathologists",
number = "6",
}
TY - JOUR
T1 - FDA oversight of laboratory-developed tests where are we now?
AU - Gatter, Ken
PY - 2017/6/1
Y1 - 2017/6/1
UR - http://www.scopus.com/inward/record.url?scp=85020165292&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85020165292&partnerID=8YFLogxK
U2 - 10.5858/arpa.2017-0053-ED
DO - 10.5858/arpa.2017-0053-ED
M3 - Editorial
C2 - 28557601
AN - SCOPUS:85020165292
VL - 141
SP - 746
EP - 748
JO - Archives of Pathology and Laboratory Medicine
JF - Archives of Pathology and Laboratory Medicine
SN - 0003-9985
IS - 6
ER -